High Dose Omeprazole in Patients With Pancreatic Cancer

High Dose Omeprazole in Patients With Pancreatic Cancer

During this study patients will receive treatment of omeprazole at the dose depending on group enrollment

Group A will receive omeprazole 80 mg, twice a day for 14 days unless unacceptable toxicity
Group B, will receive omeprazole 20 mg, once a day for 14 days

Patients will receive treatment for 2~3 weeks during the study, and 2 months of follow up.
Total accrual is anticipated to take 2 years.

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 11, 2023Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments